Alexion Pharmaceuticals, Inc. Recalls

Overview of recall records associated with Alexion Pharmaceuticals, Inc., including dates, categories and classifications where available.

2recall records

Aug 13, 2014latest record date

Feb 5, 2014earliest record date

Recall history in this database

Classification mix: Class I: 2.

DrugAug 13, 2014

Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial recall — FDA D-1512-2014

Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.

Class IFDA: TerminatedAlexion Pharmaceuticals, Inc.

DrugFeb 5, 2014

Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL recall — FDA D-1049-2014

Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.

Class IFDA: TerminatedAlexion Pharmaceuticals, Inc.

Understanding this recall history

This page summarizes recall records in which the official source identifies Alexion Pharmaceuticals, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.